跳至主要内容
临床试验/EUCTR2007-001302-25-BE
EUCTR2007-001302-25-BE进行中(未招募)不适用

Evaluation of the benefits and effects of hypericin Photodynamic therapy (PDT) in the clinical treatment of superficial bladder carcinoma.

ab for pharmaceutical biology0 个研究点开始时间: 2009年9月8日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • * Bladder tumor which requires cystectomy
  • * Anatomopathologically proven TCC
  • * No distant metastasis
  • * General condition of the patient is good enough for cystectomy
  • * life expectancy is at least 1 year
  • * TUR at least 6 weeks before cystectomy
  • * Signed informed consent
  • * instillation fluid needs to be retained in the bladder for 5 hours
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • * Distant metastatsis
  • * Life expectancy less than 1 year
  • * TUR less than 6 weeks before planned cystectomy
  • * Poor general condition whereby the patient can't undergo cystectomy
  • * Evacuation of the instillatin fluid if it is retained less than 2 hours in the bladder

研究者

发起方
ab for pharmaceutical biology

相似试验